207940.KS Loading...

Loading chart...
Top Calls
Feed
All Sources✓
YouTube✓
Twitter✓
Reddit✓
Substack✓
Insider✓
Loading...
0 selected
All directions✓
▲ Long✓
▼ Short✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
11:08
May 08
Park Ji-eun Director 3PRO TV (삼프로TV)
Samsung Biologics on CMO expansion
Samsung Biologics (207940.KS) has strong growth from CMO and capacity expansion (6th plant, US plant). The company guided $4.7 billion in orders for rest of 2026, ensuring revenue visibility. It's a long-term compounder in biopharma manufacturing.
207940.KS 1ST
MED

About 207940.KS Analyst Coverage

Buzzberg tracks 207940.KS across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 1 total trade ideas tracked.